| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/25/1999 | CN1226892A Compounds and compositions for treating diseases associated with tryptase activity |
| 08/25/1999 | CN1226886A Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation |
| 08/25/1999 | CN1226837A Steroids as neurochemical stimulators of VNO to alleviate symptoms of PMS and anxiety |
| 08/25/1999 | CN1226834A Use of (meth) acrylic acid copolymers to increase permeability of mucous membranes |
| 08/25/1999 | CN1226831A Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine |
| 08/25/1999 | CN1226828A Treatment of psychotic disorders |
| 08/25/1999 | CN1226827A Amino acid compositions and use thereof in immunosuppression |
| 08/25/1999 | CN1226826A Method of treating malignant tumours with thyroxine analogues having no significant hormonal activity |
| 08/25/1999 | CN1226825A Use of amines to produce drugs for preventing tumour cell proliferation |
| 08/25/1999 | CN1226824A Tramadol multiple unit formulations |
| 08/25/1999 | CN1226823A Pharmaceutical composition comprising coenzyme Q10 |
| 08/25/1999 | CN1226821A Microparticles |
| 08/25/1999 | CN1226803A Diphenyl heterocycles as potassium channel modulators |
| 08/25/1999 | CN1226594A Method for coal liquefaction |
| 08/25/1999 | CN1226584A The production of solid dosage forms |
| 08/25/1999 | CN1226439A Composite medicinal injection for hemiparalysis |
| 08/25/1999 | CN1226438A Composite mannosans peptides oral liquor |
| 08/25/1999 | CN1226425A Lesion-directed antibiotics in dry dosage forms for treatment of shallow ulcers of oral mucosa |
| 08/25/1999 | CN1226424A Slow releasing agent of tuduvanine and its preparing method |
| 08/25/1999 | CN1226423A Telomerase inhibitor |
| 08/25/1999 | CN1226422A Percutaneous absorption type preparation |
| 08/25/1999 | CN1044811C Pyrrolopyridazine derivatives |
| 08/25/1999 | CN1044776C Gynostemma pentaphyllum dexamethasone and its preparing method |
| 08/24/1999 | US5942631 Inhibitors of cholesterol esterase |
| 08/24/1999 | US5942624 Reacting 2,3-dichlorobenzylideneacetylacetic acid, methyl ester with ethyl 3-aminocrotonate in refluxing alcohol, ethanol as the solvent in the presence of a pyridine catalyst; fast, good yield |
| 08/24/1999 | US5942622 Novel compounds for treating illness resulting from abnormal stimulation of endothelial receptors; for example: 4-((6-chloro-1,3-benzodioxol-5-yl)methyl)-1-(cyclohexylmethyl) -3-(2-pyridinyl)-1h-pyrazole-5-carboxylate |
| 08/24/1999 | US5942619 Quinoline-4-one derivatives with optional alkyl groups at positions 1 and 3, 2-substituted with a branched unsaturated alkyl optionally substituted with hydroxyl or ether; treating ulcers; biosynthesis |
| 08/24/1999 | US5942605 Antitumor agents synthesized from anthracycline 13-tosylhydrazone; side effect reduction |
| 08/24/1999 | US5942550 Cholesterol lowering drink mix compositions |
| 08/24/1999 | US5942549 Improving glucose tolerance |
| 08/24/1999 | US5942548 Act as renin inhibitors; administering to treat cardiovascular disorders |
| 08/24/1999 | US5942547 2-Deoxystreptamine derivatives, pharmaceutical compositions thereof and therapeutic methods using same |
| 08/24/1999 | US5942545 Composition and method for treating penile erectile dysfunction |
| 08/24/1999 | US5942543 Topical anesthetic comprising lidocaine, adrenaline, and tetracaine, and its method of use |
| 08/24/1999 | US5942540 Methods of providing symptomatic and prophylactic neuroprotection |
| 08/24/1999 | US5942539 Administering to the female having endometriosis a therapeutical dosage of ateast one phytoestrogen selected from isoflavone, lignan, or coumestan |
| 08/24/1999 | US5942537 Administering a l-trans pyrrolidine derivative to inhibit the transport of l-glutamate or l-aspartate or an excitatory amino acid neurotransmitter away from a synapse comprising contacting synapse with pyrrolidine derivative |
| 08/24/1999 | US5942536 Useful for treating migraine |
| 08/24/1999 | US5942535 a!-Annelated pyrrole derivatives and pharmaceutical use thereof |
| 08/24/1999 | US5942534 Administering to the patient a photoactivatable compound selected form hematoporphyrins, benzophorphyrins, aminolevulinic acid to treat osteorthritis |
| 08/24/1999 | US5942531 Phenolic/naphtholic retinoids for promoting skin/exoskeleton pigmentation |
| 08/24/1999 | US5942530 Method for treating pain |
| 08/24/1999 | US5942529 Benzisothiazolyl-substituted aminomethylchromans |
| 08/24/1999 | US5942526 5-acyl-1,4-dihydropyridines |
| 08/24/1999 | US5942524 Serotonin(5-ht-1) agonists |
| 08/24/1999 | US5942523 Compounds which are selective antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools |
| 08/24/1999 | US5942522 1-benzyl-3-ethoxycarbonyl-4-dimethylaminoethoxy-6-methyl-2-(1h) -quinolinone; antiviral against dna containing viruses, such as herpes group viruses |
| 08/24/1999 | US5942521 Quinolinone derivative and anti-allergic agent with said quinolinone derivative as the active ingredient |
| 08/24/1999 | US5942520 Method for inhibiting neoplastic cells by exposure to substituted N-cycloalkylmethyl-1-H-pyrazolo (3,4-B) quinolone-4 amines |
| 08/24/1999 | US5942519 Administering androstene derivative 5-alpha reductase inhibitor |
| 08/24/1999 | US5942517 Antagonist of alpha(1c) receptors; treatment of benign prostatic hyperplasia |
| 08/24/1999 | US5942516 Endothelin receptor antagonists |
| 08/24/1999 | US5942515 Pyrrolopyrazolopyrimidine compound and medicine comprising the same as active ingredient |
| 08/24/1999 | US5942514 Tyrosine kinase inhibitors |
| 08/24/1999 | US5942513 Administering with diuretic suppresses efflux of antagonist through the blood-brain barrier increasing the duration of action and magnitude of effect of antagonist; treatment of stroke, schizophrenia, anxiety; antiepileptic agents |
| 08/24/1999 | US5942512 Method and composition for treating erectile dysfunction |
| 08/24/1999 | US5942511 Allylthiopyridazine derivatives and process for preparing the same |
| 08/24/1999 | US5942510 Lyophilized frozen sterile solution having a bulking agent; an antiepileptic durg |
| 08/24/1999 | US5942508 Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid |
| 08/24/1999 | US5942507 Furan nitrone compounds |
| 08/24/1999 | US5942506 1- 2-(substituted vinyl)!-5H-2,3-benzodiazepine derivatives |
| 08/24/1999 | US5942504 Amine derivatives of oxo- and hydroxy- substituted hydrocarbons |
| 08/24/1999 | US5942503 Use of Epinastine for the treatment of pain |
| 08/24/1999 | US5942502 Method of treating diseases resulting from calcium metabolism disorders |
| 08/24/1999 | US5942501 Cyclodextrin derivative complex |
| 08/24/1999 | US5942499 Method of promoting bone growth with hyaluronic acid and growth factors |
| 08/24/1999 | US5942498 Formulations containing hyaluronic acid |
| 08/24/1999 | US5942497 Purine compound and catecholamine compound containing compositions and methods for administration |
| 08/24/1999 | US5942496 Methods and compositions for multiple gene transfer into bone cells |
| 08/24/1999 | US5942434 Regulatory sequence from phophoglycerate kinase operably linked to coding sequence of exogenous gene; for gene therapy; in situ expression of enzymes which convert prodrugs to active anticarcinogenic/antitumor drugs or cytokines |
| 08/24/1999 | US5942423 Effective and relatively inexpensive method for producing anticholesterol agents using whole cells, a cell free extract, a cell free culture media, or a solution |
| 08/24/1999 | US5942255 Administering an effective amount about 600 mg/day to 4000 mg/day calcium to a person due to a calcium deficit from high intensity physical activity; the source of the calcium comprises milk-free calcium-fortified orange juice |
| 08/24/1999 | US5942253 Prolonged release of GM-CSF |
| 08/24/1999 | US5942252 Increasing the bioavailability of a drug by administering an effective amount of microcapsules to animal, the microcapsules comprising active agent encapsulated in a biocompatible and biodegradable excipient |
| 08/24/1999 | US5942251 Pharmaceutical compositions for intranasal administration of dihydroergotamine |
| 08/24/1999 | US5942250 Compositions and methods for enhancing the topical effects of sunscreen agents |
| 08/24/1999 | US5942247 Method for treating pediatric high grade astrocytoma including brain stem glioma |
| 08/24/1999 | US5942243 Mucoadhesive compositions for administration of biologically active agents to animal tissue |
| 08/24/1999 | US5942241 A sustained release drug containing a substrate comprising a local anesthetic and a biocompatible, biodegradable, controlled release polymer selected from polyanhydrides, lactic acid and glycolic acid homo-or/and copolymers |
| 08/24/1999 | US5942225 Comprising the stem cells and one or more bioactive factors for inducing differentiation of them into a single particular lineage, e.g. bone, muscle, tendon, ligament, connective tissue cells |
| 08/24/1999 | US5942218 A solution comprising polyhexamethylene biguanide; wound treatment material for both prophylaxis and treatment of infections such as an antimicrobial, antiviral, anti-parasitic material |
| 08/24/1999 | US5942209 Polymerizing a biodegradable, biocompatible polymer vehicle, e.g. epoxide-containing polymer, polyester, polyurethane, polyamide, polysulfone or an addition polymer, containing radionuclides; drug delivery |
| 08/24/1999 | US5941868 Localized intravascular delivery of growth factors for promotion of angiogenesis |
| 08/24/1999 | US5941243 Apparatus and method for ethyl chloride topical anesthesia |
| 08/24/1999 | CA2248972A1 Novel compounds |
| 08/24/1999 | CA2212548C Use of carbazole compounds for the treatment of congestive heart failure |
| 08/24/1999 | CA2193348C Substituted alkyldiamine derivatives and their use as tachykinin antagonists |
| 08/24/1999 | CA2180944C Method for delipidation of skin and cerumen removal |
| 08/24/1999 | CA2176974C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 08/24/1999 | CA2166693C Difluoro statone analogs |
| 08/24/1999 | CA2154094C Deodorant cosmetic composition superior in resistance to discoloration and dispersion |
| 08/24/1999 | CA2147126C Piperidine derivatives and process for their production |
| 08/24/1999 | CA2141969C Cardio-protective agent |
| 08/24/1999 | CA2082044C Modulation of gene expression through interference with rna secondary structure |
| 08/24/1999 | CA2075895C Compositions containing green porphyrins to destroy malignant cells in mononuclear cell populations |
| 08/24/1999 | CA2033109C Acrylic gel material and acrylic gel preparation |
| 08/24/1999 | CA2015197C Phenolic amine depigmenting and antimelanoma agents |
| 08/20/1999 | CA2261183A1 Adenoviral transfer vector for the gene transport of a dna sequence |
| 08/20/1999 | CA2249653A1 Novel compounds |
| 08/19/1999 | WO1999041404A2 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs |